TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ORANGEBIOMED

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ORANGEBIOMED

ST13

US500000099212976

Classe

10, 35, 42

Pedido

99212976

Registro

8227809

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

20

Atualização mais recente

28/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 35, 42

Data de depósito

02/06/2025

Data de registro

28/04/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/04/2026

Última transação

28/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Seoul, KR

Examinador

KOZAK, EVIN L

Unidade examinadora

O40

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Orange Biomed Co., Ltd

Representantes

April Besl Dinsmore & Shohl LLP

Classificação técnica

Classes Nice

Classe 10Classe 35Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

HbA1c monitoring cartridge unit for home use including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of medical apparatus for monitoring blood; medical test kits for HbA1c diabetes monitoring for home use; diabetic monitoring apparatus in the nature of medical test kits for diabetes monitoring for home use; HbA1c testing apparatus for diabetes monitoring in the nature of medical test kits for diabetes monitoring for home use; diabetes monitoring apparatus for analyzing HbA1c in the nature of medical test kits for diabetes monitoring for home use; HbA1c measuring apparatus for monitoring diabetes in the nature of medical test kits for diabetes monitoring for home use; biopsy needles; continuous blood glucose monitor in the nature of medical apparatus for monitoring blood glucose levels; medical apparatus and instruments other than for dental purposes for measuring blood glucose levels; medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical blood monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical apparatus for blood analysis; blood analysis apparatus for diagnosis of diabetes; blood glucose monitoring medical apparatus; medical devices for measuring blood sugar

Classe 35

Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c for home use; Retail store services featuring medical test kits for HbA1c diabetes monitoring for home use; Retail store services featuring diabetes monitoring apparatus; Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c; Retail store services featuring biopsy needles; Retail store services featuring continuous blood glucose monitor; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c; Retail store services featuring medical apparatus for blood analysis; Retail store services featuring blood analysis apparatus for diagnosis of diabetes; Retail store services featuring blood glucose monitoring apparatus

Classe 42

Development of diabetes measuring apparatus in the nature of product development; development of biopsy needles in the nature of product development; development of diagnostic preparation materials for medical and veterinary purposes in the nature of product development; development of medical apparatus and instruments other than for dental purposes in the nature of product development; development of medical diagnostic reagents in the nature of product development; development of medical apparatus for blood analysis in the nature of product development; development of test strips for measuring blood glucose levels in the nature of product development; development of medical diagnostic test strips for analyzing blood in the nature of product development

Publicações

Histórico de despachos e eventos da marca no USPTO.

20 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

28/04/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

28/04/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/03/2026

PUBO

PUBLISHED FOR OPPOSITION

10/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/02/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

02/02/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/02/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

02/02/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/02/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/01/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/01/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/01/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

24/10/2025

GNRT

NON-FINAL ACTION E-MAILED

24/10/2025

CNRT

NON-FINAL ACTION WRITTEN

24/10/2025

DOCK

ASSIGNED TO EXAMINER

21/10/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/10/2025

MAFR

APPLICATION FILING RECEIPT MAILED

02/06/2025

NWAP

NEW APPLICATION ENTERED

02/06/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ORANGEBIOMED ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.